Generics Giant Mylan Sees Growth Return In Europe
If you've ever taken a generic form of medicine, chances are you've been a customer of Mylan (MYL). The company's portfolio of generics is north of 1,100. It also sells several branded drugs, while its pharmaceutical ingredients business serves customers across 150 countries and territories. Mylan's third-quarter results, announced Oct. 25, were strong. CEO Heather Bresch noted the company saw a return to revenue growth in the Europe, Middle East
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here